Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastrointest Endosc. Jul 16, 2014; 6(7): 272-285
Published online Jul 16, 2014. doi: 10.4253/wjge.v6.i7.272
Table 1 Genetic diseases associated with pancreatic cancer risk
Risk conditionRelative riskRisk by age 70Gene
Familial pancreatic cancerPALLD
1 first-degree relative2.3-4.52%BRCA2
2 first-degree relatives6.4-183%PALB2
≥ 3 first-degree relatives32-5716%
Familial atypical multiple mole melanoma13-3815%-20%CDKN2A/p16
Peutz-Jeghers Syndrome13211%-60%STK11/LKB1
Hereditary pancreatitis50-8730%-75%PRSS1
PRSS2
SPINK1
CTRC
Cystic fibrosis5.3<5%CFTR
Familial breast ovarian cancer3.5-105%BRCA2
2.3-3.61%BRCA1
Hereditary non-polyposis colon cancer2.3-8.63%-4%MLH1
MSH2
MSH6
Familial adenomatous polyposis4.5-52%FAP
MUTYH
Li Fraumeni sindromeUnknownUnknownTP53
Table 2 Endoscopic ultrasound-based studies on screening for individuals at risk for pancreatic cancer
Ref.No. of patientsHigh-risk groupsImaging testTarget lesionsDiagnostic yieldLimits of the study
Brentnall et al[21]14FPCEUS + ERCP + CTPanIN ≥ 250%
Kimmey et al[104]46FPCEUSPanIN ≥ 226%
Canto et al[22]38FPC, PJSEUSIPMN, PC5.30%Low PPV
Canto et al[23]78FPC, PJSEUSIPMN, PC, PanIN ≥ 210.20%
Poley et al[135]44FPC, PJS, FAMMMEUSIPMN, PC22.70%No pathological confirmation of IPMN
Langer et al[103]76FPC, FAMMMEUS + MRCPIPMN1.30%Moderate risk patients
Verna et al[162]51FPC, FBOCEUS and/or MRCPIPMN, PC, PanIN ≥ 212%
Schneider et al[36]72FPC, FAMMMEUS + MRCPIPMN12.50%No pathological confirmation
Canto et al[110]216FPC, FBOC, PJSEUS + CT + MRCPIPMN, PC39%Mainly no pathological confirmation